The impact of immortal time bias on the estimated mortality benefit of antifibrotic therapy in IPF

被引：0
|
作者：
Wilskow, Marit Bjorna [1 ]
Diep, Phuong Phuong [2 ,3 ]
Hyldgaard, Charlotte [4 ]
Carlson, Lisa [5 ]
Kalafatis, Dimitrios [5 ]
Pesonen, Ida [5 ]
Skoeld, Magnus [6 ,7 ]
Shaker, Saher Burhan [8 ]
Bendstrup, Elisabeth [9 ]
Hoyer, Nils [8 ]
Durheim, Michael Thomas [2 ,3 ]
机构：
[1] Nordland Hosp, Dept Resp Med, Bodo, Norway
[2] Oslo Univ Hosp, Dept Resp Med, Rikshosp, Oslo, Norway
[3] Univ Oslo, Inst Clin Med, Oslo, Norway
[4] Silkeborg Reg Hosp, Diag Ctr, Silkeborg, Denmark
[5] Karolinska Inst, Dept Med Solna, Resp Med Unit, Stockholm, Sweden
[6] Karolinska Univ Hosp, Dept Resp Med & Allergy, Stockholm, Sweden
[7] Karolinska Inst, Dept Med Solna, Stockholm, Sweden
[8] Herlev & Gentofte Hosp, Dept Resp Med, Copenhagen, Denmark
[9] Aarhus Univ, Ctr Rare Lung Dis, Dept Resp Dis & Allergy, Dept Clin Med,Ctr Rare Lung Dis, Aarhus, Denmark
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA2433
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Impact of pulmonary vascular volume on mortality in IPF: is it time to reconsider the role of vasculature in disease pathogenesis and progression?
    Puxeddu, Ermanno
    Cavalli, Francesco
    Pezzuto, Gabriella
    Teodori, Elisa
    Rogliani, Paola
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (02)
  • [42] Impact of time to antimicrobial therapy on 28 day mortality
    Bloos, F.
    Thomas-Rueddel, D.
    Rueddel, H.
    Poidinger, B.
    Schwarzkopf, D.
    Reinhart, K.
    INFECTION, 2013, 41 : S65 - S66
  • [43] Re-evaluating the Role of Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma: Unveiling the Impact of Immortal Time Bias on Survival
    Ganjouei, Amir Ashraf
    Wang, Jane
    Romero-Hernandez, Fernando
    Peng, June
    Thornblade, Lucas W.
    Hirose, Kenzo
    Nakakura, Eric K.
    Corvera, Carlos U.
    Maker, Ajay V.
    Kirkwood, Kimberly S.
    Alseidi, Adnan
    Adam, Mohamed
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S164 - S164
  • [44] Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis A Systematic Review and Meta-Analysis
    Petnak, Tananchai
    Lertjitbanjong, Ploypin
    Thongprayoon, Charat
    Moua, Teng
    CHEST, 2021, 160 (05) : 1751 - 1763
  • [45] Immortal Time Bias in Observational Studies of Time-to-Event Outcomes: Assessing Effects of Postmastectomy Radiation Therapy Using the National Cancer Database
    Agarwal, Parul
    Moshier, Erin
    Ru, Meng
    Ohri, Nisha
    Ennis, Ronald
    Rosenzweig, Kenneth
    Mazumdar, Madhu
    CANCER CONTROL, 2018, 25 (01)
  • [46] Prognostic impact of severe neutropenia in colorectal cancer patients treated with TAS-102 and bevacizumab, addressing immortal-time bias
    Daichi Watanabe
    Hironori Fujii
    Koichi Ohata
    Hirotoshi Iihara
    Akitaka Makiyama
    Ryo Kobayashi
    Chiemi Hirose
    Shiori Hishida
    Serika Matsuoka
    Jesse Yu Tajima
    Shigeru Kiyama
    Takao Takahashi
    Akio Suzuki
    Nobuhisa Matsuhashi
    BMC Cancer, 23
  • [47] Prognostic impact of severe neutropenia in colorectal cancer patients treated with TAS-102 and bevacizumab, addressing immortal-time bias
    Watanabe, Daichi
    Fujii, Hironori
    Ohata, Koichi
    Iihara, Hirotoshi
    Makiyama, Akitaka
    Kobayashi, Ryo
    Hirose, Chiemi
    Hishida, Shiori
    Matsuoka, Serika
    Tajima, Jesse Yu
    Kiyama, Shigeru
    Takahashi, Takao
    Suzuki, Akio
    Matsuhashi, Nobuhisa
    BMC CANCER, 2023, 23 (01)
  • [48] The impact of immortal time bias and the adjustment using modified Kaplan-Meier method and time-dependent cox proportional hazard model: A case study
    Onozawa, Satoshi
    Ito, Masanori
    Kimura, Tomomi
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 377 - 378
  • [49] Characteristics of Palliative Patients, Insights of Patients and Families, and the Impact of Estimated Survival Time on Therapy Decisions
    Shatri, Hamzah
    Putranto, Rudi
    Irawan, Cosphiadi
    Adli, Mizanul
    Elita, Dina
    ACTA MEDICA INDONESIANA, 2019, 51 (02) : 151 - 157
  • [50] Impact of antifibrotic therapy on disease progression, all-cause mortality, and risk of acute exacerbation in non-IPF fibrosing interstitial lung diseases: evidence from a meta-analysis of randomized controlled trials and prospective controlled studies
    Li, De-yu
    Liu, Xin
    Huang, Jing-yi
    Hang, Wen-lu
    Yu, Gu-ran
    Xu, Yong
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2024, 18
12345